Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo

BACKGROUND: The high lifetime risk of vascular disease is one of the important issues that plague patients with diabetes mellitus. Systemic oral vildagliptin administration favors endothelial recovery and inhibits smooth muscle cell (SMC) proliferation. However, the localized release of vildagliptin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Nanomedicine
Huvudupphovsmän: Lee, Chen-Hung, Hsieh, Ming-Jer, Chang, Shang-Hung, Hung, Kuo-Chun, Wang, Chao-Jan, Hsu, Ming-Yi, Juang, Jyuhn-Huarng, Hsieh, I-Chang, Wen, Ming-Shien, Liu, Shih-Jung
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2019
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6751553/
https://ncbi.nlm.nih.gov/pubmed/31686818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S211898
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk